Ryan Specialty Holdings Inc. (NYSE:RYAN – Get Free Report) Director John Rogers, Jr. purchased 7,500 shares of Ryan Specialty stock in a transaction on Wednesday, June 10th. The shares were acquired at an average cost of $35.16 per share, for a total transaction of $263,700.00. Following the purchase, the director owned 117,933 shares in the company, valued at approximately $4,146,524.28. This trade represents a 6.79% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
Ryan Specialty Trading Down 0.6%
Shares of Ryan Specialty stock traded down $0.19 during trading hours on Thursday, reaching $34.48. 3,025,129 shares of the company’s stock were exchanged, compared to its average volume of 2,307,542. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 2.90. The firm has a market capitalization of $9.09 billion, a price-to-earnings ratio of 44.77, a price-to-earnings-growth ratio of 0.80 and a beta of 0.64. The company has a fifty day moving average of $33.56 and a 200-day moving average of $42.03. Ryan Specialty Holdings Inc. has a 52-week low of $29.28 and a 52-week high of $69.49.
Ryan Specialty (NYSE:RYAN – Get Free Report) last issued its earnings results on Thursday, April 30th. The company reported $0.47 earnings per share for the quarter, topping the consensus estimate of $0.43 by $0.04. The business had revenue of $795.23 million for the quarter, compared to analyst estimates of $781.44 million. Ryan Specialty had a return on equity of 41.33% and a net margin of 8.21%.The business’s quarterly revenue was up 15.2% on a year-over-year basis. During the same period last year, the company posted $0.39 EPS. Sell-side analysts forecast that Ryan Specialty Holdings Inc. will post 2.05 EPS for the current fiscal year.
Ryan Specialty Announces Dividend
Ryan Specialty declared that its Board of Directors has authorized a stock repurchase program on Tuesday, May 26th that permits the company to repurchase $300.00 million in outstanding shares. This repurchase authorization permits the company to purchase up to 3.5% of its shares through open market purchases. Shares repurchase programs are often a sign that the company’s management believes its stock is undervalued.
Institutional Investors Weigh In On Ryan Specialty
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. T. Rowe Price Investment Management Inc. raised its holdings in Ryan Specialty by 79.9% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 7,552,002 shares of the company’s stock worth $389,910,000 after purchasing an additional 3,353,926 shares in the last quarter. Capital World Investors grew its position in Ryan Specialty by 0.3% during the 4th quarter. Capital World Investors now owns 6,640,638 shares of the company’s stock worth $342,856,000 after purchasing an additional 17,082 shares in the last quarter. Vulcan Value Partners LLC grew its position in Ryan Specialty by 631.7% during the 4th quarter. Vulcan Value Partners LLC now owns 4,621,079 shares of the company’s stock worth $238,536,000 after purchasing an additional 3,989,502 shares in the last quarter. Principal Financial Group Inc. grew its position in Ryan Specialty by 0.9% during the 1st quarter. Principal Financial Group Inc. now owns 4,411,837 shares of the company’s stock worth $148,856,000 after purchasing an additional 37,339 shares in the last quarter. Finally, Montrusco Bolton Investments Inc. grew its holdings in shares of Ryan Specialty by 9.3% during the 4th quarter. Montrusco Bolton Investments Inc. now owns 4,343,116 shares of the company’s stock valued at $218,010,000 after acquiring an additional 368,247 shares in the last quarter. Institutional investors own 84.82% of the company’s stock.
Analyst Ratings Changes
Several research analysts have commented on RYAN shares. Morgan Stanley cut their price objective on Ryan Specialty from $45.00 to $39.00 and set an “overweight” rating on the stock in a research report on Thursday, May 21st. Wells Fargo & Company downgraded Ryan Specialty from an “overweight” rating to an “equal weight” rating and lowered their target price for the company from $42.00 to $31.00 in a research note on Friday, May 1st. Bank of America decreased their price target on Ryan Specialty from $70.00 to $68.00 and set a “buy” rating for the company in a research note on Tuesday, April 14th. JPMorgan Chase & Co. decreased their price target on Ryan Specialty from $49.00 to $43.00 and set an “underweight” rating for the company in a research note on Thursday, April 9th. Finally, UBS Group lifted their target price on Ryan Specialty from $51.00 to $52.00 and gave the company a “buy” rating in a research note on Tuesday. One investment analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, seven have issued a Hold rating and three have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $47.12.
View Our Latest Research Report on Ryan Specialty
About Ryan Specialty
Ryan Specialty Group, Inc (NYSE: RYAN) is a global specialty insurance and reinsurance platform that partners with a network of insurers and reinsurers to deliver tailored risk solutions. The company focuses on complex and large-scale risks across multiple industry sectors, leveraging its underwriting expertise to structure coverage programs that meet clients’ unique needs.
Ryan Specialty’s core offerings span a diverse range of specialty lines, including casualty, property, professional liability, marine and energy, program administration, and sports and entertainment.
See Also
- Five stocks we like better than Ryan Specialty
- Microsoft Just Gave Investors 3 Dates They Can’t Afford to Ignore
- NVIDIA’s Outlook Gains Momentum: Stock Price to Follow
- The World Cup Is Coming—These 3 Stocks Could Cash In
- Spotify’s “North Star” Outlook Was Music to Investors Ears
Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.
